PRECISION CAPITAL
ADVANCING
PRECISION HEALTH®

A PURPOSE-BUILT VENTURE FIRM

We combined accomplished investment professionals and operators with a proprietary national medical network platform to create the most unique venture firm in life sciences. MEC deploys precision capital to nurture and advance the precision health innovations that solve the biggest, most complex medical problems.

Proprietary Network of the World’s Leading Physician Scientists >
Team of Experienced VCs, Company Creators and Operators >

MEDICAL EXCELLENCE CAPITAL

A Differentiated Early-Stage Life Sciences Venture Fund >

ADVANCING THE PRECISION HEALTH DECADE

At MEC, we believe the technologies created in this decade will utilize artificial intelligence and lead to a golden age in innovation within the life sciences space. MEC invests in company creation, seed, Series A, and Series B opportunities where technology and novel approaches are transformative for patient care and directly address large, unmet needs. Our areas of focus include:

 

 

 

 

OUR PORTFOLIO

Aspen Neuroscience
Aspen Neuroscience
Active
Immunitas Therapeutics
Active
Nobias Therapeutics
Active
ProJenX
ProJenX
Active
View All

NEWS & BLOG

View the latest posts and investment news from MEC.

Press Release
GC Therapeutics Appoints Kate Haviland as Board Chair and Provides Corporate Update
Read More
Press Release
SonoThera Launches $125M Series B at 44th J.P. Morgan Healthcare Conference to Advance Multiple Genetic Medicine Programs Toward First-in-Human Studies
Read More
Press Release
Aspen Neuroscience Completes Phase 1/2a ASPIRO Trial Cohort Three Dosing and State-of-the-Art Manufacturing Expansion, Paving the Way for Developing Transformative Therapies for Patients
Read More
Press Release
Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer
Read More
View All

TAKE THE NEXT STEP

Contact us today for more information about MEC.

GET IN TOUCH